• Font Size    
Advertising
E-mail

Close Window E-mail This Page

Key 'Switch' Found For Popular Breast Cancer Drug

Required fields are marked with an asterisk(*)



The information you provide will be used only to send the requested e-mail and will not be used to send any other e-mail communications. Read more in our Privacy Policy

Send E-mail

   Print     Share +    Comments

Key 'Switch' Found For Popular Breast Cancer Drug

WASHINGTON (AP) ― Scientists have pinpointed the molecular on-off switch that the powerful drug tamoxifen uses to attack breast cancer and which prevents it from working in some women.

That discovery should eventually help doctors test for resistance to the drug, the chief treatment for breast cancers that are estrogen-driven, researchers said. Tamoxifen doesn't work in about one-quarter to one-third of women who are treated with it.

A test for resistance based on the research, published in Thursday's editions of the journal Nature, is probably about five years away, said study co-author Jason Carroll, a cancer researcher at the Cambridge Research Institute in the United Kingdom.

Tamoxifen turns off a gene that causes tumors to grow, but sometimes it fails in a molecular tug-of-war with another protein, and that's when the drug doesn't work, Carroll said.

"If that switch fails, the tamoxifen fails," he said. "The switch is hidden in the background of the genome in the gene itself."

About 40,500 women die each year of breast cancer in the United States, according to the American Cancer Society.

(© 2010 The Associated Press. All Rights Reserved. This material may not be published, broadcast, rewritten, or redistributed.)

Add Comment

here. here. Need a log in? Register here
  •  * Will not be displayed with comment
  •  * e.g. (http://www.mywebsite.com)
  •  
  • Click here to refresh with new letters

Close Window Login


Close Window Flag Comment


loading...